Pfizer's earnings beat forecast, but shares fall as company's outlook disappoints

Pharmaceutical giant Pfizer reported fourth-quarter earnings and revenue on Tuesday that beat Wall Street's expectations but guidance for 2019 came below estimates. Shares of Pfizer fell more than 3 percent in premarket trading. Pfizer expects 2019 earnings between $2.82 a share and $2.92 a share, below the $3.04 estimate Wall Street expected.